Atlas Trials

CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer

Clinical trial NCT05795335 · RECRUITING

Trial details

NCT number
NCT05795335
Sponsor
RenJi Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2023-04-30
Primary completion
2026-04-30
Enrollment
172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.